ATLAS / Macro Radar / Reporting / CTNM

Contineum Therapeutics, Inc. (CTNM) reporting calendar

Contineum Therapeutics, Inc. files periodic reports with the SEC as CTNM on Nasdaq. Atlas tracks 9 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
23 Jul 2026 – 26 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
5 May 2026
Reports on record
9

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 40 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open CTNM market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20265 May 202635 days0001628280-26-030614
10-K31 Dec 20255 Mar 202664 days0001628280-26-015165
10-Q30 Sep 202530 Oct 202530 days0001437749-25-032427
10-Q30 Jun 20255 Aug 202536 days0001437749-25-024852
10-Q31 Mar 202514 May 202544 days0001437749-25-016835
10-K31 Dec 20246 Mar 202565 days0001437749-25-006458
10-Q30 Sep 20246 Nov 202437 days0001437749-24-033616
10-Q30 Jun 202414 Aug 202445 days0001437749-24-026680
10-Q31 Mar 202416 May 202446 days0001437749-24-017320

Source: SEC EDGAR company submissions for CIK 0001855175. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.